Search - tctmd.com

Displaying 401 - 420 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Lessons Learned from Early FIH/EFS Trials: Transcatheter Pulmonary Valve Replacement

Presenter: John G. Webb, Ajit Yoganathan, John P. Cheatham

October 30, 2016

Presentation TCT 2016

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

Presenter: Vivek Y. Reddy, Steven J. Yakubov

October 30, 2016

Presentation TCT 2016

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, David J. Cohen

October 30, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? YES, the Data Is Sufficient and Our Patients Want It!

Presenter: Russell A. Brandwein, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries

Presenter: Mitchell W. Krucoff, Shigeru Saito, Christopher B. Granger

October 30, 2016

Presentation TCT 2016

Treatment Options After Unsuccessful Aortic Valve Replacement

Presenter: Alejandro Cherro, Oscar A. Mendiz

October 30, 2016

Presentation TCT 2016

Simultaneous TAVR and Endovascular Aortic Aneurysm Repair

Presenter: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab, Walid Ouertani

October 30, 2016

Presentation TCT 2016

Flash Debate: Counterpoint Stay the Course: We Need the Next Round of Low-Risk Randomized TAVR Studies AND Long-Term Follow-up to Justify Changes!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Lars G. Svensson

October 30, 2016

Presentation TCT 2016

Procedural Guidance: Beyond TEE - ICE, Navigator, and More

Presenter: Paul A. Grayburn, Patrizio Lancellotti, Brij Maini

October 30, 2016

Presentation TCT 2016

Flash Debate: Point Surgical Risk Stratification for TAVR Should Be Replaced by Anatomic and Clinical Profiling!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies

Presenter: John G. Webb, Ajit Yoganathan, Scott Lim

October 30, 2016

Presentation TCT 2016

Epicardial Closure of the LAA With the Lariat: What Do we Know About Its Safety and Efficacy?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Matthew J. Price

October 30, 2016

Presentation TCT 2016

TCT 648: Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Jean-Claude Laborde, Azfar G. Zaman

October 30, 2016

Presentation TCT 2016

TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High Risk Pulmonary Embolism: A Meta-Analysis

Presenter: Irene M. Lang, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Emerging Role of CT for Assessment of Mitral Valve Anatomy and Dysfunction

Presenter: Paul A. Grayburn, Patrizio Lancellotti, Hasan Jilaihawi

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma

October 30, 2016

Presentation TCT 2016

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Marc Gillinov

October 30, 2016

Presentation TCT 2016

Lessons Learned from Early FIH/EFS Trials: Mitral Valve Replacement and Repair Technologies

Presenter: John G. Webb, Ajit Yoganathan, Vinayak Bapat

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack

October 30, 2016

Presentation TCT 2016

Strengths and Weaknesses of CMR for Quantification of MR

Presenter: Paul A. Grayburn, Patrizio Lancellotti, Stamatios Lerakis

October 30, 2016

Advertisement

Lessons Learned from Early FIH/EFS Trials: Transcatheter Pulmonary Valve Replacement

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Debate: TAVR for Low Risk Patients Is It time? YES, the Data Is Sufficient and Our Patients Want It!

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries

Treatment Options After Unsuccessful Aortic Valve Replacement

Simultaneous TAVR and Endovascular Aortic Aneurysm Repair

Flash Debate: Counterpoint Stay the Course: We Need the Next Round of Low-Risk Randomized TAVR Studies AND Long-Term Follow-up to Justify Changes!

Procedural Guidance: Beyond TEE - ICE, Navigator, and More

Flash Debate: Point Surgical Risk Stratification for TAVR Should Be Replaced by Anatomic and Clinical Profiling!

Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies

Epicardial Closure of the LAA With the Lariat: What Do we Know About Its Safety and Efficacy?

TCT 648: Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High Risk Pulmonary Embolism: A Meta-Analysis

Emerging Role of CT for Assessment of Mitral Valve Anatomy and Dysfunction

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Lessons Learned from Early FIH/EFS Trials: Mitral Valve Replacement and Repair Technologies

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Strengths and Weaknesses of CMR for Quantification of MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content